Stockscreener 앱 받기
206.32
2.64%
5.2217
Resmed Inc 주식(RMD)의 최신 뉴스
ResMed (RMD) Added to Goldman Sachs' APAC Conviction List - GuruFocus
Is It Too Late to Buy ResMed Inc (RMD) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
ResMed (RMD) Upgraded to Buy: Here's Why - Yahoo Finance UK
Wall Street Analysts Think ResMed (RMD) Could Surge 28.21%: Read This Before Placing a Bet - Yahoo Finance
ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares - Stock Titan
ResMed (RMD) Stock Looks Cheap Even As The Market Stays Cautious - Yahoo Finance
Resmed to report Q4FY26 earnings on August 6, 2026 - scanx.trade
Should ResMed’s Russell Growth Index Exit and Volatility Spike Require Action From ResMed (RMD) Investors? - Yahoo Finance
ResMed Gets PTAB To Ax 1 Out Of 2 Sleep Apnea Patents - Law360
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026 - The Manila Times
Resmed sets Aug. 6 webcast for fiscal Q4 results - Stock Titan
ResMed Inc options activity points to a potential volatility spike. Consensus earnings expectations - AD HOC NEWS
ResMed leads sleep apnea market with strong growth and margin improvements, rated Buy with 12% safety margin. - Pluang
ResMed: Fear-Driven Selloff Creates A Compelling Margin Of Safety Entry Point - Seeking Alpha
ResMed Inc.(NYSE: RMD) dropped from Russell Midcap Growth Benchmark - marketscreener.com
Are Options Traders Betting on a Big Move in ResMed Stock? - Yahoo Finance
ResMed adjusts index footprint, shares hold gains on NYSE and ASX - AD HOC NEWS
ResMed Inc.(NYSE: RMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
ResMed Inc.(NYSE: RMD) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Daily Brief Australia: Cochlear Ltd, Commonwealth Bank of Australia, Fortescue Metals, ResMed Inc and more - Smartkarma
ResMed Inc.(NYSE: RMD) dropped from Russell 3000 Growth Benchmark - marketscreener.com
AirSense 10 ClimateLineAir Heated Tube from ResMed Inc.quieter nights with smarter humidity - Ad-hoc-news.de
ResMed muted ahead of next earnings, shares trade steadily on NYSE - Ad-hoc-news.de
Enterprise value to EBIT forward of ResMed Inc. – NYSE:RMD - TradingView
OLD National Bancorp IN Has $4.58 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. sees fresh institutional buying, shares hover near 200 dollars - Ad-hoc-news.de
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh - TradingView
Price to earnings forward of ResMed Inc. – NYSE:RMD - TradingView
Price to earnings forward of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – MUN:RMEA - TradingView
Price to sales forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed clears key trading range, shares hold firm between support and resistance - Ad-hoc-news.de
Enterprise value to revenue forward of ResMed Inc. – NYSE:RMD - TradingView
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed clears a fresh 52-week high, shares extend their Nasdaq run - Ad-hoc-news.de
Why ResMed Inc (RMD) Is Set to Outperform the Market: Insights i - GuruFocus
Price to book forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed Stock is Down 20% in 2026. Is It a Buying Opportunity or a Warning Sign? - TIKR.com
ResMed Inc. Actuals & Estimates (NYSE:RMD) - TradingView
ResMed (ASX:RMD) Stock Moves Higher — What Investors Should Know? - Kalkine
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues? - Insider Monkey
Enterprise value to EBITDA forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed opens the week with clear technical signals, shares trade in a defined range - Ad-hoc-news.de
Resmed Inc (RMD) Institutional Confidence - TradingKey
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative? - Sahm
Resmed Inc (RMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Resmed Inc (RMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Should I buy CSL and ResMed shares right now? - The Motley Fool Australia
ResMed downgraded at Morgan Stanley on Philips re-entry and GLP-1 headwinds - MSN
ResMed edges higher after mixed analyst signals, shares trade near recent targets - AD HOC NEWS
Could ResMed (NYSE:RMD) Be Entering a New Chapter in Sleep Care? - Kalkine Media
ResMed trims KeyBanc price target, analyst views on the shares stay constructive - AD HOC NEWS
William Blair Maintains ResMed(RMD.US) With Buy Rating - Moomoo
KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating - marketscreener.com
ResMed Inc. (RMD) Stock Analysis: Unveiling A 39% Potential Upside Amidst Solid Growth - DirectorsTalk Interviews
Resmed Inc (RMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Announces Target Price $266 - Moomoo
Is ResMed (NYSE:RMD) Market Reset Creating New Interest? - Kalkine Media
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley - The Globe and Mail
Resmed Inc (RMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is ResMed stock underperforming the Dow? - MSN
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos - The Globe and Mail
Resmed Inc (RMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Resmed Inc (RMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ResMed Is Near Its 52-Week Low Despite 21% EPS Growth: What the GLP-1 Fear Is Getting Wrong - TIKR.com
ResMed Loses Bull as Margin Outlook Moderates -- Market Talk - Moomoo
Resmed Closes Acquisition of Noctrix Health - Moomoo
2.71%
자본화:
|
볼륨(24시간):